Track topics on Twitter Track topics that are important to you
EXTRACTA was incorporated in 1998 as a private LLC company created by scientists interested in the relationship between biodiversity and biotechnology. It started activities in 1999 as a resident company under the umbrella of BIO-RIO Foundation, the private operator of the BIO-RIO Science Park on the campus of UFRJ – the Federal University of Rio de Janeiro. EXTRACTA grew to become a full corporation (a “sociedade anônima”) by year 2000. EXTRACTA invested circa five million US dollars in its 700m2 of laboratory and related facilities and has accumulated considerable experience in contract research and technical services. It has amassed the largest collection of plant extracts, fractions and purecompounds in Brazil, the EXTRACTA Bank of Chemical Bio diversity. The Company is fully equipped to perform high throughput screening of its collection against innovative biological targets. It uses state-of-the-art analytical methods in tandem with bioassays in order to
isolate novel pure compounds of intere st to Pharma, Cosmetics, Fragrances, Crop and Livestock Defense and New Biomaterials.
In June 2004 EXTRACTA became the first Brazilian corporation to receive from the Ministry of the Environment (CGEN) a Special License to access national biodiversity and to form a commercial library of extracts and its derivatives, down to pure compounds. This license
makes EXTRACTA an attractive partner for industrial clients who seek to use biodiversity as a source of innovation of their chemical product pipelines. EXTRACTA is controlled (close to 90%) by its founders, AVFS Participações e Consultoria Ltda, a group of Brazilian investors and scientists. The Managing Director of AVFS is also the Chairman and CEO of EXTRACTA.
Pólo Bio-RioAvenida 24, sem númeroCidade Universitária
Ilha do Fundão
Rio de Janeiro
Phone: (55-21) 3867-5608
Fax: (55-21) 3867-5609
Ante cualquier agresión, el organismo pone en marcha una respuesta inflamatoria, mediada por factores humorales y celulares, que tiende a limitar el proceso y a conseguir la curación. En algunos cas...
Introduction. Multiple sclerosis (MS) is the most common neurological disease causing disability in young adults. Neurorehabilitation is a fundamental aspect in the treatment approach for ...
EXTRACTA was incorporated in 1998 as a private LLC company created by scientists interested in the relationship between biodiversity and biotechnology. It started activities in 1999 as a resident com...
Cultek fue constituida en Madrid en 1976. Su actividad principal es la distribución de productos y servicios para laboratorios de Ciencias de la Vida. Nuestros clientes son los centros de investigac...
We have published hundreds of EXTRACTA MOLÉCULAS NATURAIS S/A news stories on BioPortfolio along with dozens of EXTRACTA MOLÉCULAS NATURAIS S/A Clinical Trials and PubMed Articles about EXTRACTA MOLÉCULAS NATURAIS S/A for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EXTRACTA MOLÉCULAS NATURAIS S/A Companies in our database. You can also find out about relevant EXTRACTA MOLÉCULAS NATURAIS S/A Drugs and Medications on this site too.
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...